MedTrace Logo

Effectiveness of Anthroposophic Speech Therapy in Patients With Asthma

NCT02501824 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2015-07-17

No results posted yet for this study

Summary

Anthroposophic therapeutic speech is a complementary method that indirectly influences breathing and uses specific vowels, consonants, syllables and metres depending on the indication. The aim of this study is to test the effectiveness of anthroposophic therapeutic speech in patients with asthma regarding clinical and physiological parameters, asthma control and quality of life.

Conditions

Interventions

OTHER

anthroposophic therapeutic speech

anthroposophic therapeutic speech

Sponsors & Collaborators

  • University of Bern

    lead OTHER

Principal Investigators

  • Ursula Wolf · Institute of Complementary Medicine, University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2014-08-31
Completion
2014-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501824 on ClinicalTrials.gov